Intravenous therapy for hypertensive emergencies, part 2

American Journal of Health-System Pharmacy

Volumn 66, Issue 16, 2009, Pages 1448-1457

  Rhoney, Denise ^a   Peacock, W Frank ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Clevidipine; Drugs; Emergencies; Enalaprilat; Esmolol; Fenoldopam; Hydralazine; Hypertension; Hypotensive agents; Injections; Labetalol; Nicardipine; Nitroglycerin; Nitroprusside; Phentolamine

Indexed keywords

ALTEPLASE; ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; CLEVIDIPINE; DOBUTAMINE; DOPAMINE; ENALAPRILAT; ESMOLOL; FENOLDOPAM; FUROSEMIDE; GLYCERYL TRINITRATE; HYDRALAZINE; LABETALOL; METOPROLOL; NESIRITIDE; NICARDIPINE; NIFEDIPINE; NITROPRUSSIDE SODIUM; NORADRENALIN; PHENTOLAMINE; PHOSPHODIESTERASE INHIBITOR; TADALAFIL; TRIACYLGLYCEROL; URAPIDIL;

ACUTE CORONARY SYNDROME; ANGINA PECTORIS; AORTA DISSECTION; BLOOD PRESSURE REGULATION; BOLUS INJECTION; BRADYCARDIA; BRAIN HEMORRHAGE; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; CONTINUOUS INFUSION; CORONARY ARTERY BYPASS SURGERY; DISEASE SEVERITY; DOSE RESPONSE; DRUG ACTIVITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECLAMPSIA; ECLAMPSIA AND PREECLAMPSIA; FLUSHING; HEADACHE; HEART LEFT VENTRICLE FAILURE; HEART PALPITATION; HUMAN; HYPERTENSIVE CRISIS; HYPERTENSIVE EMERGENCY; HYPOTENSION; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; NAUSEA; NEUROLOGIC DISEASE; NORADRENALIN BLOOD LEVEL; PERIOPERATIVE PERIOD; PHEOCHROMOCYTOMA; PRACTICE GUIDELINE; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SUBARACHNOID HEMORRHAGE; TACHYCARDIA; THORAX PAIN; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES; VOMITING;

EID: 69249227499     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp080348.p2     Document Type: Review

References (62)

1. Rhoney D, Peacock WF. Intravenous antihypertensive therapy for hypertensive emergencies, part 1. Am J Health-Syst Pharm. 2009; 66:1343-1352
2. Yang HJ, Kim JG, Lim YS et al. Nicardipine versus nitroprusside infusion as antihypertensive therapy in hypertensive emergencies. J In t Med Res. 2004; 32:118-23.
3. Neutel JM, Smith DH, Wallin D et al. A comparison of intravenous nicardipine and sodium nitroprusside in the immediate treatment of severe hypertension. Am J Hypertens. 1994; 7:623-628 (Pubitemid 24265158)
4. Panacek EA, Bednarczyk EM, Dunbar LM et al. Randomized, prospective trial of fenoldopam vs sodium nitroprusside in the treatment of acute severe hypertension. Fenoldopam Study Group. Acad Emerg Med. 1995; 2:959-965
5. Elliott WJ, Weber RR, Nelson KS et al. Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension. Circulation. 1990; 81:970-977
6. Tumlin JA, Dunbar LM, Oparil S et al. Fenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial. Acad Emerg Med. 2000; 7:653-662 (Pubitemid 30390491)
7. Pollack CV, Varon J, Garrison NA et al. Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension. Ann Emerg Med. 2009; 53:329-338
8. Varon J, Peacock W, Garrison N et al. Prolonged infusion of clevidipine results in safe and predictable blood pressure control in patients with acute severe hypertension. Paper presented at the Annual Meeting of the American College of Chest Physicians. Chicago, IL; 2007 Oct.
9. Cressman MD, Vidt DG, Gifford RW Jr et al. Intravenous labetalol in the management of severe hypertension and hypertensive emergencies. Am Heart J. 1984; 107:980-985
10. Britton M, Carlsson A, de Faire U. Blood pressure course in patients with acute stroke and matched controls. Stroke. 1986; 17:861-864 (Pubitemid 16000718)
11. Jorgensen HS, Nakayama H, Christensen HR et al. Blood pressure in acute stroke. The Copenhagen Stroke Study. Cerebrovasc Dis. 2002; 13:204-209
12. Morler JR, Tilley BC, Lu M et al. Early stroke treatment associated with better outcomes: the NINDS rt-PA stroke study. Neurology. 2000; 55:1649-1655
13. Willmot M, Leonardi-Bee J, Bath PM. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension. 2004; 43:18-24. (Pubitemid 38031905)
14. Carlberg B, Asplund K, Hagg E. The prognostic value of admission blood pressure in patients with acute stroke. Stroke. 1993; 24:1372-1375 (Pubitemid 23254642)
15. Jorgensen HS, Nakayama H, Raaschou HO et al. Effect of blood pressure and diabetes on stroke in progression. Lancet. 1994; 344:156-159 (Pubitemid 24218878)
16. Leonardi-Bee J, Bath PM, Phillips SJ et al. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke. 2002; 33:1315-1320
17. Vemmos KN, Tsivgoulis G, Spengos K et al. U-shaped relationship between mortality and admission blood pressure in patients with acute stroke. J Intern Med. 2004; 255:257-265 (Pubitemid 38241370)
18. Castillo J, Leira R, Garcia MM et al. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke. 2004; 35:520-526 (Pubitemid 38174440)
19. Stead LG, Gilmore RM, Decker WW et al. Initial emergency department blood pressure as predictor of survival after acute ischemic stroke. Neurology. 2005; 65:1179-1183
20. Lisk DR, Grotta JC, Lamki LM et al. Should hypertension be treated after acute stroke? A randomized controlled trial using single photon emission computed tomography. Arch Neurol. 1993; 50:855-862
21. Bath P, Pathansali R, Iddenden R et al. The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovasc Dis. 2001; 11:265-272
22. Schrader J, Luders S, Kulschewski A et al. The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke. 2003; 34:1699-1703 (Pubitemid 36842630)
23. Adams HP Jr, del Zoppo G, Alberts MJ et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007; 38:1655-1711 [Errata, Stroke. 2007; 38:e38, e96.]
24. American Heart Association. Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Part 9: adult stroke. Circulation. 2005; 112:IV111-20.
25. Broderick J, Connolly S, Feldmann E et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke. 2007; 38:2001-2023
26. Qureshi AI, Ezzeddine MA, Nasar A et al. Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med. 2007; 25:32-38 (Pubitemid 44869006)
27. Davis SM, Broderick J, Hennerici M et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 2006; 66:1175-1181
28. Kazui S, Naritomi H, Yamamoto H et al. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke. 1996; 27:1783-1787
29. Ohwaki K, Yano E, Nagashima H et al. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke. 2004; 35:1364-1367 (Pubitemid 38697459)
30. Qureshi AI, Wilson DA, Hanley DF et al. No evidence for an ischemic penumbra in massive experimental intracerebral hemorrhage. Neurology. 1999; 52:266-272 (Pubitemid 29059050)
31. Carhuapoma JR, Wang PY, Beauchamp NJ et al. Diffusion-weighted MRI and proton MR spectroscopic imaging in the study of secondary neuronal injury after intracerebral hemorrhage. Stroke. 2000; 31:726-732
32. Zazulia AR, Diringer MN, Videen TO et al. Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab. 2001; 21:804-810
33. Kidwell CS, Saver JL, Mattiello J et al. Diffusion-perfusion MR evaluation of perihematomal injury in hyperacute intracerebral hemorrhage. Neurology. 2001; 57:1611-1617 (Pubitemid 33055479)
34. Powers WJ, Zazulia AR, Videen TO et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology. 2001; 57:18-24.
35. Qureshi AI. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH): rationale and design. Neurocrit Care. 2007; 6:56-66.
36. American Heart Association. Intensive anti-hypertensive treatment may control blood clot after stroke. http://americanheart.mediaroom.com/index.php?s= 43&item=338 (accessed 2008 Mar 1).
37. ClinicalTrials.gov. Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH). http://clinicaltrials.gov/ct2/show/NCT00415610?term= atach&rank=1 (accessed 2008 Oct 20).
38. Anderson CS, Huang Y, Wang JG et al. Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008; 7:391-399
39. Koch S, Romano JG, Forteza AM et al. Rapid blood pressure reduction in acute intracerebral hemorrhage: feasibility and safety. Neurocrit Care. 2008; 8:316-321
40. Qureshi AI, Harris-Lane P, Kirmani JF et al. Treatment of acute hypertension in patients with intracerebral hemorrhage using American Heart Association guidelines. Crit Care Med. 2006; 34:1975-80. (Pubitemid 43982476)
41. Qureshi AI, Mohammad YM, Yahia AM et al. A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage. J Intensive Care Med. 2005; 20:34-42.
42. Liu-DeRyke X, Janisse J, Coplin W et al. A comparison of nicardipine and labetalol for treating acute hypertension following stroke. Neurocrit Care. 2008; 9:167-176
43. Eagle KA, Berger PB, Calkins H et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation. 2002; 105:1257-1267
44. Kwak YL, Oh YJ, Bang SO et al. Comparison of the effects of nicardipine and sodium nitroprusside for control of increased blood pressure after coronary artery bypass graft surgery. J Int Med Res. 2004; 32:342-350
45. Dorman T, Thompson DA, Breslow MJ et al. Nicardipine versus nitroprusside for breakthrough hypertension following carotid endarterectomy. J Clin Anesth. 2001; 13:16-19 (Pubitemid 32208688)
46. Bailey JM, Lu W, Levy JH et al. Clevidipine in adult cardiac surgical patients: a dose-finding study. Anesthesiology. 2002; 96:1086-1094 (Pubitemid 34462568)
47. Levy JH, Mancao MY, Gitter R et al. Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1. Anesth Analg. 2007; 105:918-925 (Pubitemid 47479301)
48. Varon J, Levy J, Dyke C et al. Precise and ultrarapid control of blood pressure with clevidipine, an arterial selective calcium channel blocker. Crit Care. 2007; 11(suppl 2):P242.
49. Singla N, Warltier DC, Gandhi SD et al. Treatment of acute postoperative hypertension in cardiac surgery patients: an efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized, double-blind, placebo-controlled trial. Anesth Analg. 2008; 107:59-67.
50. Aronson S, Dyke CM, Stierer KA et al. The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. Anesth Analg. 2008; 107:1110-1121
51. Elliott WJ. Clinical features and management of selected hypertensive emergencies. J Clin Hypertens. 2004; 6:587-592
52. Lunell NO, Lewander R, Nylund L et al. Acute effect of dihydralazine on utero-placental blood flow in hypertension during pregnancy. Gynecol Obstet Invest. 1983; 16:274-282
53. Elatrous S, Nouira S, Ouanes Besbes L et al. Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol. Intensive Care Med. 2002; 28:1281-1286 (Pubitemid 35025047)
54. Huey J, Thomas JP, Hendricks DR et al. Clinical evaluation of intravenous labetalol for the treatment of hypertensive urgency. Am J Hypertens. 1988; 1:284S-289S. (Pubitemid 18176622)
55. Mabie WC, Gonzalez AR, Sibai BM et al. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol. 1987; 70:328-333
56. Morel DR, Forster A, Suter PM. I.V. labetalol in the treatment of hypertension following coronary-artery surgery. Br J Anaesth. 1982; 54:1191-1196
57. Vigil-De Gracia P, Lasso M, Ruiz E et al. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial. Eur J Obstet Gynecol Reprod Biol. 2006; 128:157-162 (Pubitemid 44322020)
58. Kloner RA, Hutter AM, Emmick JT et al. Time course of the interaction between tadalafil and nitrates. J Am Coll Cardiol. 2003; 42:1855-1860
59. Chae C, Hennekes C. Beta blockers. In: Hennekens C, ed. Clinical trials in cardiovascular disease: a companion to Braunwald's heart disease. Philadelphia: Saunders; 1999:79-94.
60. Chen ZM, Pan HC, Chen YP et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005; 366:1622-32.
61. Swedberg K, Held P, Kjekshus J et al. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med. 1992; 327:678-684
62. Levy P, Compton S, Welch R et al. Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis. Ann Emerg Med. 2007; 50:144-52. (Pubitemid 47069604)